Aging Pharmaceuticals Revolution

Celine shares her vision for developing a multibillion-dollar company focused on aging drugs for dogs, which also holds potential insights for human aging. With a unique perspective on how dogs serve as biological models, she emphasizes the significance of understanding age-related diseases in canines to inform human health. Her ambition is to create a leading pharmaceutical company in the aging sector, aiming to surpass traditional oncology markets.